China H7N9 Bird Flu Vaccine Passes Animal Test As Cases Reach 120
This article was originally published in PharmAsia News
Executive Summary
China researchers reported success so far in trials of a genetically engineered vaccine against the H7N9 avian influenza virus plaguing the country just as the case count reached 120, more than 25 of them fatal.